Adam Feuerstein

TheStreet.com Senior Columnist

Before joining TheStreet.com in March 2001, Feuerstein covered business software for Upside.com. Prior to that he covered a variety of business beats, including technology and commercial real estate, at the San Francisco Business Times.

Feuerstein graduated from Emory University with a bachelor's degree in political science.

Adam Feuerstein
By This Author:
« Back
Page 1 of 402
Article

Blood Cancer Meeting Abstracts Released: BioBuzz

By Adam Feuerstein

No data in Celgene abstract, disappointing investors.

11:14AM 11/10/09

Article

Bristol Licenses Arthritis Drug: BioBuzz

By Adam Feuerstein

Worldwide deal involves privately held Alder BioTherapeutics

09:20AM 11/10/09

Article

Celgene in ASH Abstract Spotlight: BioBuzz

By Adam Feuerstein

A blood cancer meeting also is important for Onyx, Cephalon and Ariad.

06:31AM 11/10/09

Article

Doc Offers Top Hep C Drug Picks: BioBuzz

By Adam Feuerstein

Vertex, InterMune, Pharmasset get positive reviews after recent Hep C meeting.

01:54PM 11/09/09

Article

Xoma Waffles on Timing of Drug Partnership: BioBuzz

By Adam Feuerstein

An expected deal for its diabetes drug may not happen until next year.

10:23AM 11/09/09

Article

Ariad Upgraded, Xenoport Drug Delayed: BioBuzz

By Adam Feuerstein

Analysts sees upside in two Ariad drugs while FDA delays decision on Xenoport drug.

07:51AM 11/09/09

Article

Oculus, Bianco and Cel-Sci Oh My!: BioBuzz

By Adam Feuerstein

Some Friday Fall tidbits from the biotech stock world.

10:53AM 11/06/09

Article

Biotech Stock Mailbag: Poniard Predictions

By Adam Feuerstein

Readers chime in on Poniard Pharmaceuticals, Chelsea Therapeutics, AMAG, Cel-Sci and Dendreon.

07:00AM 11/06/09

Article

BioCryst Competition for IV Flu Drug: BioBuzz

By Adam Feuerstein

U.S. government orders IV versions of two flu drugs to treat hospitalized patients.

06:29AM 11/06/09

Article

BioCryst Winners and Losers: BioBuzz

By Adam Feuerstein

Sorting out the latest salvo in the H1N1 investor war

02:32PM 11/05/09

« Back
Page 1 of 402
Dow Jones S&P 500 NASDAQ 10-Year Note
10,239.19 1,092.35 2,149.65 34.82
Oil *
77.52
UP
12.25
DOWN
0.72
DOWN
4.41
DOWN
0.04
10 Yr
3.48%
SPDR Gold
108.35
+0.12%
-0.07%
-0.20%
-0.11%
Data delayed 20 minutes

Brokerage Partners